← brief for 2026-08-26 · Slowing decline

A Study to Evaluate Safety, Tolerability and Efficacy of AP306 at Fixed Doses in Dialysis Participants With Hyperphosphatemia

Key takeaways

This trial will test how safe and well-tolerated a drug called AP306 is at fixed doses in people on dialysis who have high phosphate levels. There are no results yet—this is a planned study to measure safety and effectiveness.

Who did this work

Run by R1 Therapeutics.
Sites: Apogee Clinical Research, LLC · California Institute of Renal Research · Academic Medical Research Institute · North America Research Institute · Colorado Kidney Care · DaVita Clinical Research

Source

Trial · ClinicalTrials.gov, CKD recruiting · 2026-08-26
https://clinicaltrials.gov/study/NCT06712654